BCM
TRIL

Bourgeon Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bourgeon Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,000
Closed -$228K – 301
2021
Q3 		$228K Sell
13,000
-27,250
-68% -$478K 0.05% 102
2021
Q2 		$390K Buy
40,250
+10,000
+33% +$96.9K 0.08% 91
2021
Q1 		$325K Buy
30,250
+7,000
+30% +$75.2K 0.07% 96
2020
Q4 		$342K Buy
+23,250
New +$342K 0.08% 84